{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:25Z","timestamp":1786979965514,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001636","name":"University College Cork","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001636","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with rheumatoid arthritis (RA) have an elevated risk of developing cardiovascular disease (CVD). Despite European guidelines recommending routine CVD risk assessment, implementation in clinical practice is challenging. The objectives of this review were to determine if patients attending an Irish tertiary rheumatology centre received CVD risk assessments in line with European guidelines and assess the extent of CVD risk factor screening over five years of routine rheumatology care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective chart review was conducted for patients newly diagnosed with RA in 2018, with five-year follow-up. Data were extracted to determine if CVD risk assessments were performed, and where absent, risk was retrospectively calculated. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement checklist for cohort studies was used to guide the reporting of this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 21 patients, no documented CVD risk assessments were identified. CVD risk factor screening was consistently insufficient. There was a lack of documented clinical data necessary to conduct a CVD risk assessment on more than half of patients at study entry, and one quarter of patients at five-year follow up. Of those with data available (n\u2009=\u200910), retrospective calculations showed 80% had an undetected moderate or higher CVD risk at diagnosis. There was no documented referral to primary care for CVD risk assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementation of CVD risk management guidelines in the routine care of patients with RA is challenging. The interpretation and operationalisation of guideline recommendations by rheumatology healthcare professionals in relation to implementation barriers needs to be explored.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00296-025-05916-1","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:04:50Z","timestamp":1750925090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-1087","authenticated-orcid":false,"given":"Louise","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-7724","authenticated-orcid":false,"given":"Grainne","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0644-0026","authenticated-orcid":false,"given":"Nicola","family":"Cornally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-0491","authenticated-orcid":false,"given":"Sheena","family":"McHugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7277-6268","authenticated-orcid":false,"given":"Mohamad M.","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-9421","authenticated-orcid":false,"given":"Patrick","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"issue":"3","key":"5916_CR1","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/rheumatology\/keaa374","volume":"60","author":"BB L\u00f8gstrup","year":"2021","unstructured":"L\u00f8gstrup BB, Ellingsen T, Pedersen AB et al (2021) Cardiovascular risk and mortality in rheumatoid arthritis compared with diabetes mellitus and the general population. Rheumatology (Oxford) 60(3):1400\u20131409. https:\/\/doi.org\/10.1093\/rheumatology\/keaa374","journal-title":"Rheumatology (Oxford)"},{"key":"5916_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100108","volume":"8","author":"N Johri","year":"2023","unstructured":"Johri N, Varshney S, Gandha S et al (2023) Association of cardiovascular risks in rheumatoid arthritis patients: management, treatment and future perspectives. Health Sci Rev 8:100108. https:\/\/doi.org\/10.1016\/j.hsr.2023.100108","journal-title":"Health Sci Rev"},{"issue":"12","key":"5916_CR3","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M et al (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690\u20131697. https:\/\/doi.org\/10.1002\/art.24092","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5916_CR4","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","volume":"48","author":"C Meune","year":"2009","unstructured":"Meune C, Touz\u00e9 E, Trinquart L, Allanore Y (2009) Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 48(10):1309\u20131313. https:\/\/doi.org\/10.1093\/rheumatology\/kep252","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5916_CR5","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M et al (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71(9):1524\u20131529. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200726","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5916_CR6","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3899\/jrheum.200842","volume":"48","author":"E Myasoedova","year":"2021","unstructured":"Myasoedova E, Davis JM, Roger VL et al (2021) Improved incidence of cardiovascular disease in patients with incident rheumatoid arthritis in the 2000s: a population-based cohort study. J Rheumatol 48(9):1379\u20131387. https:\/\/doi.org\/10.3899\/jrheum.200842","journal-title":"J Rheumatol"},{"issue":"10","key":"5916_CR7","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/annrheumdis-2016-211066","volume":"76","author":"M Holmqvist","year":"2017","unstructured":"Holmqvist M, Ljung L, Askling J (2017) Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks. Ann Rheum Dis 76(10):1642\u20131647. https:\/\/doi.org\/10.1136\/annrheumdis-2016-211066","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5916_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.semarthrit.2021.03.003","volume":"51","author":"K Yazdani","year":"2021","unstructured":"Yazdani K, Xie H, Avina-Zubieta JA et al (2021) Has the excess risk of acute myocardial infarction in rheumatoid arthritis relative to the general population declined? A population study of trends over time. Semin Arthritis Rheum 51(2):442\u2013449. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.003","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"5916_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180376","volume":"12","author":"K Zou","year":"2017","unstructured":"Zou K, Xiao FK, Li HY et al (2017) Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: a cross-sectional study based on hospital medical records in 10 years. PLoS ONE 12(7):e0180376. https:\/\/doi.org\/10.1371\/journal.pone.0180376","journal-title":"PLoS ONE"},{"issue":"3","key":"5916_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/rheumatology\/kez371","volume":"59","author":"SA Provan","year":"2020","unstructured":"Provan SA, Lillegraven S, Sexton J et al (2020) Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study. Rheumatology (Oxford) 59(3):505\u2013512. https:\/\/doi.org\/10.1093\/rheumatology\/kez371","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5916_CR11","doi-asserted-by":"publisher","first-page":"23985","DOI":"10.1038\/s41598-021-03407-4","volume":"11","author":"JW Groenendyk","year":"2021","unstructured":"Groenendyk JW, Rivera AS, Sinha A et al (2021) Changes in proportionate cardiovascular mortality in patients with chronic infectious and inflammatory conditions in the United States, 1999\u20132018. Sci Rep 11(1):23985. https:\/\/doi.org\/10.1038\/s41598-021-03407-4","journal-title":"Sci Rep"},{"issue":"2","key":"5916_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/RHU.0000000000001818","volume":"28","author":"NN Shah","year":"2022","unstructured":"Shah NN, Wass S, Hajjari J et al (2022) Proportionate cardiovascular mortality in chronic inflammatory disease in adults in the United States from 1999 to 2019. J Clin Rheumatol 28(2):97\u2013103. https:\/\/doi.org\/10.1097\/RHU.0000000000001818","journal-title":"J Clin Rheumatol"},{"issue":"4","key":"5916_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s40744-023-00562-0","volume":"10","author":"KB Almutairi","year":"2023","unstructured":"Almutairi KB, Inderjeeth CA, Preen DB et al (2023) Mortality trends among patients with rheumatoid arthritis in Western Australia. Rheumatol Ther 10(4):1021\u20131037. https:\/\/doi.org\/10.1007\/s40744-023-00562-0","journal-title":"Rheumatol Ther"},{"issue":"1","key":"5916_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","volume":"80","author":"S Dadoun","year":"2013","unstructured":"Dadoun S, Zeboulon-Ktorza N, Combescure C et al (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine 80(1):29\u201333. https:\/\/doi.org\/10.1016\/j.jbspin.2012.02.005","journal-title":"Joint Bone Spine"},{"issue":"8","key":"5916_CR15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/acr.22553","volume":"67","author":"J Widdifield","year":"2015","unstructured":"Widdifield J, Bernatsky S, Paterson JM et al (2015) Trends in excess mortality among patients with rheumatoid arthritis in Ontario. Canada Arthritis Care Res (Hoboken) 67(8):1047\u20131053. https:\/\/doi.org\/10.1002\/acr.22553","journal-title":"Canada Arthritis Care Res (Hoboken)"},{"issue":"4","key":"5916_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00296-016-3638-5","volume":"37","author":"J van den Hoek","year":"2017","unstructured":"van den Hoek J, Boshuizen HC, Roorda LD et al (2017) Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study. Rheumatol Int 37(4):487\u2013493. https:\/\/doi.org\/10.1007\/s00296-016-3638-5","journal-title":"Rheumatol Int"},{"issue":"1","key":"5916_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 76(1):17\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5916_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4078\/jrd.2023.0030","volume":"30","author":"JH Koh","year":"2023","unstructured":"Koh JH, Lee BW, Kim WU (2023) Changes in the cholesterol profile of patients with rheumatoid arthritis treated with biologics or Janus kinase inhibitors. J Rheum Dis 30(4):234\u2013242. https:\/\/doi.org\/10.4078\/jrd.2023.0030","journal-title":"J Rheum Dis"},{"issue":"6","key":"5916_CR19","doi-asserted-by":"publisher","first-page":"R270","DOI":"10.1186\/ar4118","volume":"14","author":"SS Desai","year":"2012","unstructured":"Desai SS, Myles JD, Kaplan MJ (2012) Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther 14(6):R270. https:\/\/doi.org\/10.1186\/ar4118","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"5916_CR20","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3899\/jrheum.160241","volume":"43","author":"CE Barber","year":"2016","unstructured":"Barber CE, Esdaile JM, Martin LO et al (2016) Gaps in addressing cardiovascular risk in rheumatoid arthritis: assessing performance using cardiovascular quality indicators. J Rheumatol 43(11):1965\u20131973. https:\/\/doi.org\/10.3899\/jrheum.160241","journal-title":"J Rheumatol"},{"issue":"10","key":"5916_CR21","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/rheumatology\/key164","volume":"57","author":"TJ Schmidt","year":"2018","unstructured":"Schmidt TJ, Avi\u00f1a-Zubieta JA, Sayre EC et al (2018) Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines. Rheumatology (Oxford) 57(10):1789\u20131794. https:\/\/doi.org\/10.1093\/rheumatology\/key164","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"5916_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s10067-024-06996-3","volume":"43","author":"L Murphy","year":"2024","unstructured":"Murphy L, Saab MM, Cornally N et al (2024) Cardiovascular disease risk assessment in patients with rheumatoid arthritis: a scoping review. Clin Rheumatol 43(7):2187\u20132202. https:\/\/doi.org\/10.1007\/s10067-024-06996-3","journal-title":"Clin Rheumatol"},{"issue":"8","key":"5916_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M et al (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147(8):573\u2013577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010","journal-title":"Ann Intern Med"},{"key":"5916_CR24","unstructured":"Central Statistics Office (2022) Census 2022 Summary Results FY003A-Population. Census 2022. [Online] https:\/\/data.cso.ie\/ Accessed 8 May 2025"},{"key":"5916_CR25","unstructured":"Health Service Executive (HSE) (2023) Model 3 Hospitals Report. [Online]. https:\/\/www.hse.ie\/eng\/staff\/leadership-education-development\/met\/publications\/model-3-report1.pdf Accessed 8 May 2025"},{"issue":"10","key":"5916_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/annrheumdis-2018-213700","volume":"77","author":"RBM Landew\u00e9","year":"2018","unstructured":"Landew\u00e9 RBM (2018) Overdiagnosis and overtreatment in rheumatology: a little caution is in order. Ann Rheum Dis 77(10):1394\u20131396. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213700","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5916_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/1756-185X.12164","volume":"17","author":"D Nicholls","year":"2013","unstructured":"Nicholls D, Zochling J, Boers A et al (2013) A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice. Int J Rheum Dis 17(7):755\u2013761. https:\/\/doi.org\/10.1111\/1756-185X.12164","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"5916_CR28","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3899\/jrheum.141251","volume":"42","author":"ZJ LoVerde","year":"2015","unstructured":"LoVerde ZJ, Mandl LA, Johnson BK et al (2015) Rheumatoid arthritis does not increase risk of short-term adverse events after total knee arthroplasty: a retrospective case-control study. J Rheumatol 42(7):1123\u20131230. https:\/\/doi.org\/10.3899\/jrheum.141251","journal-title":"J Rheumatol"},{"issue":"4","key":"5916_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00296-021-04811-9","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Inderjeeth C, Preen DB et al (2021) The accuracy of administrative health data for identifying patients with rheumatoid arthritis: a retrospective validation study using medical records in Western Australia. Rheumatol Int 41(4):741\u2013750. https:\/\/doi.org\/10.1007\/s00296-021-04811-9","journal-title":"Rheumatol Int"},{"issue":"9","key":"5916_CR30","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5916_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.18553\/jmcp.2022.28.9.1046","volume":"28","author":"J Qian","year":"2022","unstructured":"Qian J, Xue X, Shannon J (2022) Characteristics of adverse event reporting of Xeljanz\/Xeljanz XR, Olumiant, and Rinvoq to the US food and drug administration. J Manag Care Spec Pharm 28(9):1046\u20131052. https:\/\/doi.org\/10.18553\/jmcp.2022.28.9.1046","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"5916_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41584-022-00767-7","volume":"18","author":"KL Winthrop","year":"2022","unstructured":"Winthrop KL, Cohen SB (2022) Oral surveillance and JAK inhibitor safety: the theory of relativity. Nat Rev Rheumatol 18(5):301\u2013304. https:\/\/doi.org\/10.1038\/s41584-022-00767-7","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"5916_CR33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg SR, Bhatt DL, Mikuls TR, ORAL Surveillance Investigators et al (2022) Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 386(4):316\u2013326. https:\/\/doi.org\/10.1056\/NEJMoa2109927","journal-title":"N Engl J Med"},{"issue":"2","key":"5916_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10067-022-06415-5","volume":"42","author":"DP Misra","year":"2022","unstructured":"Misra DP, Pande G, Agarwal V (2022) Cardiovascular risks associated with Janus kinase inhibitors: peering outside the black box. Clin Rheumatol 42(2):621\u2013632. https:\/\/doi.org\/10.1007\/s10067-022-06415-5","journal-title":"Clin Rheumatol"},{"issue":"4","key":"5916_CR35","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s12325-023-02445-w","volume":"40","author":"PC Taylor","year":"2023","unstructured":"Taylor PC, Bieber T, Alten R et al (2023) Baricitinib safety for events of special interest in populations at risk: analysis from randomised trial data across rheumatologic and dermatologic indications. Adv Ther 40(4):1867\u20131883. https:\/\/doi.org\/10.1007\/s12325-023-02445-w","journal-title":"Adv Ther"},{"issue":"25","key":"5916_CR36","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42(25):2439\u20132454. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309","journal-title":"Eur Heart J"},{"issue":"25","key":"5916_CR37","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","volume":"42","author":"SCORE2-OP working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2-OP working group and ESC Cardiovascular risk collaboration (2021) SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J 42(25):2455\u20132467. https:\/\/doi.org\/10.1093\/eurheartj\/ehab312","journal-title":"Eur Heart J"},{"issue":"12","key":"5916_CR38","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2024","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M et al (2024) 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension: endorsed by the international society of hypertension (ISH) and the European renal association (ERA). J Hypertens 41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"key":"5916_CR39","unstructured":"Health Service Executive (2021) Model of care for management of overweight and obesity. Royal College of Physicians in Ireland [Online] https:\/\/www.hse.ie\/eng\/about\/who\/cspd\/ncps\/obesity\/model-of-care\/obesity-model-of-care.pdf Accessed 28 May 2025"},{"key":"5916_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/B0-12-386860-2\/00384-1","volume-title":"Encyclopedia of gastroenterology","author":"M Chandalia","year":"2004","unstructured":"Chandalia M, Abate N (2004) Hyperlipidemia. In: Johnson LR (ed) Encyclopedia of gastroenterology. Elsevier, New York, pp 403\u2013410"},{"key":"5916_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fpubh.2020.00177","volume":"8","author":"H He","year":"2020","unstructured":"He H, Pan L, Cui Z et al (2020) Smoking prevalence, patterns, and cessation among adults in Hebei province, Central China: implications from china national health survey (CNHS). Front Public Health 8:177. https:\/\/doi.org\/10.3389\/fpubh.2020.00177","journal-title":"Front Public Health"},{"issue":"10","key":"5916_CR42","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s10067-011-1747-9","volume":"30","author":"SO Keeling","year":"2011","unstructured":"Keeling SO, Teo M, Fung D (2011) Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clin Rheumatol 30(10):1311\u20131317. https:\/\/doi.org\/10.1007\/s10067-011-1747-9","journal-title":"Clin Rheumatol"},{"key":"5916_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2099","volume":"357","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C, Brindle P (2017) Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 357:j2099. https:\/\/doi.org\/10.1136\/bmj.j2099","journal-title":"BMJ"},{"issue":"3","key":"5916_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/1744666X.2022.2039630","volume":"18","author":"F Atzeni","year":"2022","unstructured":"Atzeni F, Popa CD, Nucera V, Nurmohamed MT (2022) Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events. Expert Rev Clin Immunol 18(3):233\u2013244. https:\/\/doi.org\/10.1080\/1744666X.2022.2039630","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"5916_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/acr.22689","volume":"68","author":"CM Bartels","year":"2016","unstructured":"Bartels CM, Roberts TJ, Hansen KE et al (2016) Rheumatologist and primary care management of cardiovascular disease risk in rheumatoid arthritis: patient and provider perspectives. Arthritis Care Res (Hoboken) 68(4):415\u2013423. https:\/\/doi.org\/10.1002\/acr.22689","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"5916_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/msc.1196","volume":"16","author":"K Ladak","year":"2018","unstructured":"Ladak K, Hashim J, Clifford-Rashotte M et al (2018) Cardiovascular risk management in rheumatoid arthritis: a large gap to close. Musculoskeletal Care 16(1):152\u2013157. https:\/\/doi.org\/10.1002\/msc.1196","journal-title":"Musculoskeletal Care"},{"issue":"1","key":"5916_CR47","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12872-022-02674-x","volume":"22","author":"J Sewell","year":"2022","unstructured":"Sewell J, Hussain SM, Wang Y et al (2022) Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk. BMC Cardiovasc Disord 22(1):232. https:\/\/doi.org\/10.1186\/s12872-022-02674-x","journal-title":"BMC Cardiovasc Disord"},{"key":"5916_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152233","volume":"62","author":"R Raadsen","year":"2023","unstructured":"Raadsen R, Hansildaar R, van Kuijk AWR, Nurmohamed MT (2023) Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women. Semin Arthritis Rheum 62:152233. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152233","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"5916_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40744-019-00189-0","volume":"7","author":"DJ DeMizio","year":"2020","unstructured":"DeMizio DJ, Geraldino-Pardilla LB (2020) Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Ther 7(1):19\u201333. https:\/\/doi.org\/10.1007\/s40744-019-00189-0","journal-title":"Rheumatol Ther"},{"issue":"5","key":"5916_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/rheumatology\/keu376","volume":"54","author":"CH Im","year":"2015","unstructured":"Im CH, Kim NR, Kang JW et al (2015) Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis. Rheumatology (Oxford) 54(5):808\u2013815. https:\/\/doi.org\/10.1093\/rheumatology\/keu376","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"5916_CR51","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3390\/medicina59091550","volume":"59","author":"D Bedekovi\u0107","year":"2023","unstructured":"Bedekovi\u0107 D, Bo\u0161njak I, \u0160ari\u0107 S et al (2023) Role of inflammatory cytokines in rheumatoid arthritis and development of atherosclerosis: a review. Medicina (Kaunas) 59(9):1550. https:\/\/doi.org\/10.3390\/medicina59091550","journal-title":"Medicina (Kaunas)"},{"issue":"3","key":"5916_CR52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.41122","volume":"72","author":"GA Karpouzas","year":"2020","unstructured":"Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ (2020) Impact of cumulative inflammation, cardiac risk factors, and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis. Arthritis Rheumatol 72(3):400\u2013408. https:\/\/doi.org\/10.1002\/art.41122","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"5916_CR53","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1186\/ar3442","volume":"13","author":"L Innala","year":"2011","unstructured":"Innala L, M\u00f6ller B, Ljung L et al (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13(4):R131. https:\/\/doi.org\/10.1186\/ar3442","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5916_CR54","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1144","volume":"9","author":"Z Varga","year":"2017","unstructured":"Varga Z, Sabzwari SRA, Vargova V (2017) Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue. Cureus 9(4):e1144. https:\/\/doi.org\/10.7759\/cureus.1144","journal-title":"Cureus"},{"issue":"1","key":"5916_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13075-016-1157-0","volume":"18","author":"F Verhoeven","year":"2016","unstructured":"Verhoeven F, Prati C, Maguin-Gat\u00e9 K et al (2016) Glucocorticoids and endothelial function in inflammatory diseases: focus on rheumatoid arthritis. Arthritis Res Ther 18(1):258. https:\/\/doi.org\/10.1186\/s13075-016-1157-0","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"5916_CR56","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.mayocp.2020.12.035","volume":"96","author":"J Bilal","year":"2021","unstructured":"Bilal J, Riaz IB, Naqvi SAA et al (2021) Janus kinase inhibitors and risk of venous thromboembolism: a systematic review and meta-analysis. Mayo Clin Proc 96(7):1861\u20131873. https:\/\/doi.org\/10.1016\/j.mayocp.2020.12.035","journal-title":"Mayo Clin Proc"},{"key":"5916_CR57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jsbmb.2018.08.010","volume":"185","author":"TTH Do","year":"2019","unstructured":"Do TTH, Marie G, H\u00e9lo\u00efse D et al (2019) Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration. J Steroid Biochem Mol Biol 185:150\u2013162. https:\/\/doi.org\/10.1016\/j.jsbmb.2018.08.010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"5916_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69(2):325\u2013331. https:\/\/doi.org\/10.1136\/ard.2009.113696","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5916_CR59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1136\/annrheumdis-2013-204531","volume":"74","author":"EE Arts","year":"2015","unstructured":"Arts EE, Fransen J, den Broeder AA et al (2015) The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis 74(6):998\u20131003. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204531","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"5916_CR60","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1136\/annrheumdis-2012-202398","volume":"72","author":"AM Kerola","year":"2013","unstructured":"Kerola AM, Kerola T, Kauppi MJ et al (2013) Cardiovascular comorbidities antedating the diagnosis of rheumatoid arthritis. Ann Rheum Dis 72(11):1826\u20131829. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202398","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"5916_CR61","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/heartjnl-2019-316193","volume":"106","author":"E Nikiphorou","year":"2020","unstructured":"Nikiphorou E, de Lusignan S, Mallen CD et al (2020) Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study. Heart 106(20):1566\u20131572. https:\/\/doi.org\/10.1136\/heartjnl-2019-316193","journal-title":"Heart"},{"issue":"4","key":"5916_CR62","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/acr.23612","volume":"71","author":"CM Bartels","year":"2019","unstructured":"Bartels CM, Ramly E, Johnson HM et al (2019) Connecting rheumatology patients to primary care for high blood pressure: specialty clinic protocol improves follow-up and population blood pressures. Arthritis Care Res (Hoboken) 71(4):461\u2013470. https:\/\/doi.org\/10.1002\/acr.23612","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"5916_CR63","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/acr.24589","volume":"74","author":"CM Bartels","year":"2022","unstructured":"Bartels CM, Johnson L, Ramly E et al (2022) Impact of a rheumatology clinic protocol on tobacco cessation quit line referrals. Arthritis Care Res (Hoboken) 74(9):1421\u20131429. https:\/\/doi.org\/10.1002\/acr.24589","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"5916_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13690-024-01256-x","volume":"82","author":"JK Karstensen","year":"2024","unstructured":"Karstensen JK, Bremander A, Nielsen KE et al (2024) Patients\u2019 perspectives on adherence to cardiovascular screening consultation and lifestyle changes. Arch Public Health 82(1):30. https:\/\/doi.org\/10.1186\/s13690-024-01256-x","journal-title":"Arch Public Health"},{"issue":"5","key":"5916_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/03009742.2019.1600718","volume":"48","author":"M Heslinga","year":"2019","unstructured":"Heslinga M, Van Den Oever I, Jonker DL et al (2019) Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme. Scand J Rheumatol 48(5):345\u2013352. https:\/\/doi.org\/10.1080\/03009742.2019.1600718","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"5916_CR66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41927-024-00378-7","volume":"8","author":"JK Karstensen","year":"2024","unstructured":"Karstensen JK, Bremander A, Christensen JR, Primdahl J (2024) Participation in cardiovascular screening consultations, the who, when and why - a cohort study on patients with rheumatoid arthritis. BMC Rheumatol 8(1):8. https:\/\/doi.org\/10.1186\/s41927-024-00378-7","journal-title":"BMC Rheumatol"},{"key":"5916_CR67","unstructured":"O\u2019Brien M, Scott A (2016) Making every contact count. A Health Behaviour Change Framework and Implementation Plan for Health Professionals in the Irish Health Service. Health Service Executive (HSE) [Online] https:\/\/www.hse.ie\/eng\/about\/who\/healthwellbeing\/making-every-contact-count\/making-every-contact-count-framework.pdf Accessed 14 May 2025"},{"key":"5916_CR68","unstructured":"Health Service Executive [Internet] https:\/\/hse.ie\/"},{"issue":"1","key":"5916_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40744-018-0137-z","volume":"6","author":"P Sunkureddi","year":"2019","unstructured":"Sunkureddi P, Latremouille-Viau D, Meiselbach MK et al (2019) Characteristics of patients with psoriatic arthritis receiving secukinumab and reasons for initiation: a US retrospective medical chart review. Rheumatol Ther 6(1):89\u2013100. https:\/\/doi.org\/10.1007\/s40744-018-0137-z","journal-title":"Rheumatol Ther"},{"issue":"8","key":"5916_CR70","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3899\/jrheum.100979","volume":"38","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Nicola PJ et al (2011) The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 38(8):1601\u20131606. https:\/\/doi.org\/10.3899\/jrheum.100979","journal-title":"J Rheumatol"},{"issue":"9","key":"5916_CR71","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3899\/jrheum.160670","volume":"44","author":"MLT Berendsen","year":"2017","unstructured":"Berendsen MLT, van Maaren MC, Arts EEA et al (2017) Anticyclic citrullinated peptide antibodies and rheumatoid factor as risk factors for 10-year cardiovascular morbidity in patients with rheumatoid arthritis: a large inception cohort study. J Rheumatol 44(9):1325\u20131330. https:\/\/doi.org\/10.3899\/jrheum.160670","journal-title":"J Rheumatol"},{"issue":"7","key":"5916_CR72","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204792","volume":"73","author":"AG Semb","year":"2014","unstructured":"Semb AG, Rollefstad S, van Riel P et al (2014) Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice. Ann Rheum Dis 73(7):1284\u20131288. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204792","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5916_CR73","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12875-022-01744-5","volume":"23","author":"AL Yailian","year":"2022","unstructured":"Yailian AL, Estublier C, Fontana A et al (2022) Practices among general practitioners in rheumatoid arthritis (GEPRA-I): results of a region-wide online survey. BMC Prim Care 23(1):144. https:\/\/doi.org\/10.1186\/s12875-022-01744-5","journal-title":"BMC Prim Care"},{"issue":"9","key":"5916_CR74","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/rheumatology\/kew497","volume":"56","author":"IAM van den Oever","year":"2017","unstructured":"van den Oever IAM, Heslinga M, Griep EN et al (2017) Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the implementation of cardiovascular risk management in rheumatoid arthritis project. Rheumatology (Oxford) 56(9):1472\u20131478. https:\/\/doi.org\/10.1093\/rheumatology\/kew497","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"5916_CR75","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2013-203682","volume":"72","author":"J Primdahl","year":"2013","unstructured":"Primdahl J, Clausen J, H\u00f8rslev-Petersen K (2013) Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann Rheum Dis 72(11):1771\u20131776. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203682","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"5916_CR76","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1136\/annrheumdis-2012-202789","volume":"72","author":"S Rollefstad","year":"2012","unstructured":"Rollefstad S, Kvien TK, Holme I et al (2012) Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Ann Rheum Dis 72(12):1968\u20131974. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202789","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5916_CR77","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kex054","volume":"56","author":"CD Popa","year":"2017","unstructured":"Popa CD (2017) Cardiovascular risk management in rheumatoid arthritis: challenges ahead. Rheumatology (Oxford) 56(9):1443\u20131444. https:\/\/doi.org\/10.1093\/rheumatology\/kex054","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"5916_CR78","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/RHU.0000000000000726","volume":"24","author":"CM Bartels","year":"2018","unstructured":"Bartels CM, Johnson H, AlcarazVoelker K et al (2018) Frequency and predictors of communication about high blood pressure in rheumatoid arthritis visits. J Clin Rheumatol 24(4):210\u2013217. https:\/\/doi.org\/10.1097\/RHU.0000000000000726","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"5916_CR79","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00296-020-04691-5","volume":"40","author":"AD Jamthikar","year":"2020","unstructured":"Jamthikar AD, Gupta D, Puvvula A et al (2020) Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging. Rheumatol Int 40(12):1921\u20131939. https:\/\/doi.org\/10.1007\/s00296-020-04691-5","journal-title":"Rheumatol Int"},{"key":"5916_CR80","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00296-020-04677-3","volume":"40","author":"T Dimitroulas","year":"2020","unstructured":"Dimitroulas T, Baniotopoulos P, Pagkopoulou E et al (2020) Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study. Rheumatol Int 40:1997\u20132004. https:\/\/doi.org\/10.1007\/s00296-020-04677-3","journal-title":"Rheumatol Int"},{"key":"5916_CR81","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00296-023-05333-2","volume":"43","author":"M Ausserwinkler","year":"2023","unstructured":"Ausserwinkler M, Neumann HJ, Wernly B (2023) Rheumatoid arthritis and cardiovascular risk: keep it simple and compassionate. Rheumatol Int 43:1557\u20131558. https:\/\/doi.org\/10.1007\/s00296-023-05333-2","journal-title":"Rheumatol Int"},{"issue":"11","key":"5916_CR82","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s10067-019-04651-w","volume":"38","author":"Y Haviv-Yadid","year":"2019","unstructured":"Haviv-Yadid Y, Segal Y, Dagan A et al (2019) Mortality of patients with rheumatoid arthritis requiring intensive care: a single-center retrospective study. Clin Rheumatol 38(11):3015\u20133023. https:\/\/doi.org\/10.1007\/s10067-019-04651-w","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5916_CR83","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10067-015-3166-9","volume":"35","author":"A Contis","year":"2016","unstructured":"Contis A, Vanquaethem H, Truchetet ME et al (2016) Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review. Clin Rheumatol 35(2):517\u2013522. https:\/\/doi.org\/10.1007\/s10067-015-3166-9","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5916_CR84","doi-asserted-by":"publisher","first-page":"kex390.053","DOI":"10.1093\/rheumatology\/kex390.053","volume":"56","author":"K Robinson","year":"2017","unstructured":"Robinson K, Lowry C, O\u2019Keefe N et al (2017) Retrospective review of the hypermobility physiotherapy exercise program in children Attending TSCUH. Rheumatology (Oxford) 56(7):kex390.053. https:\/\/doi.org\/10.1093\/rheumatology\/kex390.053","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05916-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05916-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:43:41Z","timestamp":1757198621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05916-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":84,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["5916"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05916-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that this manuscript is original research and has not been submitted for publication elsewhere. Furthermore, our study has not been presented, nor is it currently under consideration for presentation, at any scientific meeting or conference in any form. All authors made substantial contributions to the design of this study. LM and LM undertook the pilot to evaluate the data extraction tool. LM extracted and analysed the data under the supervision of GM. Analysed data were reviewed by all co-authors. Each author made substantial contributions to data interpretation and subsequent conclusions drawn. LM wrote and formatted the paper under the supervision of all other co-authors. Each co-author critically reviewed the manuscript for intellectual content and approved this final version for publication. All authors agree to be accountable for all aspects of this work, ensuring information accuracy and research integrity throughout. No professional editing services or artificial intelligence programmes were used in the writing or editing of this manuscript. All authors declare that they have no conflicts of interest to disclose in any capacity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"158"}}